Over the past three months, Novavax has lost nearly half its value. That's about to change, and here is how you can profit. Read More

We’ve endured a rough 2020, but 2021 beckons with the promise of renewed economic growth fueled by technological innovation. Read More

The end of electioneering and the emergence of COVID vaccines are fueling a relief rally in stocks. A bull market probably awaits investors in 2021. Read More

Investors are getting whipsawed by election and pandemic news, but through it all, the market is demonstrating upward momentum. Read More

The pandemic is getting worse, contradicting previous optimism that it was on the wane. And yet, underlying fundamentals remain bullish. Read More

In this interview, one of our top experts explains why political and economic conditions are bullish in the run-up to 2021 and beyond. Read More

The November 3 elections witnessed the passage by wide margins of ballot measures to curb prohibitions on psychedelics. A major industry is being born. Read More

Despite its noisy aftermath, the election is over. Investors should position their portfolios for the inevitable transfer of power. Read More

Now that the 2020 presidential election is over and a new vaccine is on the horizon, investors are giddy. We examine whether the rally can last. Read More

The third quarter continued the market recovery that began in the second quarter, but the economy is still flashing warning signs. Read More